Lupin eyes acquisitions, remains committed to emerging markets

Drug maker Lupin would not scale down its operations in emerging markets despite currency fluctuations and the company would look at acquisition opportunities in specialty product business for growth, its managing director Nilesh Gupta said here on Tuesday. Lupin, which acquired drug firm Medquimica in Brazil last year, is now […]